Skip to main content

Published

International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based study.
Morgan E. The Lancet Oncology 2026;:https://doi.org/10.1016/S1470-2045(26)00089-6.
[Analysis of 2.6M cancer cases across seven countries found a 16% drop (≈55,700 cases) in diagnoses during April–Dec 2020 vs expected trends, especially for prostate, breast, and melanoma. Declines were greatest early in lockdowns, likely due to reduced healthcare access. Further research is needed on delayed diagnoses and stage at presentation.]
Freely available online

Age Groups
Adults
Conditions and Lifestyle Factors
Cancer
Coronavirus Infections
Pandemics
Settings
End of Life Care in Hospital
Hospital Ward
Intensive Care
Outpatient Department
Staff Groups
Medic
Nurse Specialist
Public Health Doctor